BLAIR WILLIAM & CO/IL - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 62 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2020$13,000
+8.3%
12,0000.0%0.00%
Q3 2020$12,000
-7.7%
12,0000.0%0.00%
Q2 2020$13,000
-40.9%
12,000
-45.5%
0.00%
Q1 2020$22,000
-12.0%
22,0000.0%0.00%
Q4 2019$25,000
+78.6%
22,000
+83.3%
0.00%
Q3 2019$14,0000.0%12,0000.0%0.00%
Q2 2019$14,000
-12.5%
12,0000.0%0.00%
Q1 2019$16,000
+23.1%
12,000
-99.9%
0.00%
Q4 2018$13,0000.0%12,000,000
+99900.0%
0.00%
Q2 2017$13,0000.0%12,0000.0%0.00%
Q1 2017$13,000
+8.3%
12,0000.0%0.00%
Q4 2016$12,00012,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders